These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12769682)

  • 1. Beta galactosidase enzyme fragment complementation as a novel technology for high throughput screening.
    Eglen RM; Singh R
    Comb Chem High Throughput Screen; 2003 Jun; 6(4):381-7. PubMed ID: 12769682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists.
    Golla R; Seethala R
    J Biomol Screen; 2002 Dec; 7(6):515-25. PubMed ID: 14599349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme fragment complementation: a flexible high throughput screening assay technology.
    Eglen RM
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):97-104. PubMed ID: 15090161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of beta-galactosidase enzyme complementation technology as a high throughput screening format for antagonists of the epidermal growth factor receptor.
    Graham DL; Bevan N; Lowe PN; Palmer M; Rees S
    J Biomol Screen; 2001 Dec; 6(6):401-11. PubMed ID: 11788058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
    Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
    J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta galactosidase enzyme fragment complementation as a high-throughput screening protease technology.
    Naqvi T; Lim A; Rouhani R; Singh R; Eglen RM
    J Biomol Screen; 2004 Aug; 9(5):398-408. PubMed ID: 15296639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homogeneous assays for cellular protein degradation using beta-galactosidase complementation: NF-kappaB/IkappaB pathway signaling.
    Zhao X; Vainshtein I; Gellibolian R; Shu Y; Dotimas H; Wang XM; Fung P; Horecka J; Bosano BL; Eglen RM
    Assay Drug Dev Technol; 2003 Dec; 1(6):823-33. PubMed ID: 15090228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the utility of beta-galactosidase complementation: piece by piece.
    Broome AM; Bhavsar N; Ramamurthy G; Newton G; Basilion JP
    Mol Pharm; 2010 Feb; 7(1):60-74. PubMed ID: 19899815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
    Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
    J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the InteraX system technology in a high-throughput screening environment.
    Büttner FH; Kumpf R; Menzel S; Reulle D; Valler MJ
    J Biomol Screen; 2005 Aug; 10(5):485-94. PubMed ID: 16093558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions.
    Galarneau A; Primeau M; Trudeau LE; Michnick SW
    Nat Biotechnol; 2002 Jun; 20(6):619-22. PubMed ID: 12042868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha complementation of LacZ in mammalian cells.
    Moosmann P; Rusconi S
    Nucleic Acids Res; 1996 Mar; 24(6):1171-2. PubMed ID: 8604354
    [No Abstract]   [Full Text] [Related]  

  • 13. A homogeneous cell-based assay to measure nuclear translocation using beta-galactosidase enzyme fragment complementation.
    Fung P; Peng K; Kobel P; Dotimas H; Kauffman L; Olson K; Eglen RM
    Assay Drug Dev Technol; 2006 Jun; 4(3):263-72. PubMed ID: 16834532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilities of uncomplemented and complemented M15 beta-galactosidase (Escherichia coli) and the relationship to alpha-complementation.
    Gallagher CN; Huber RE
    Biochem Cell Biol; 1999; 77(2):109-18. PubMed ID: 10438145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Galactosidase alpha-complementation. A model of protein-protein interaction.
    Zabin I
    Mol Cell Biochem; 1982 Nov; 49(2):87-96. PubMed ID: 6818452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Tri-part Protein Complementation System Using Antibody-Small Peptide Fusions Enables Homogeneous Immunoassays.
    Dixon AS; Kim SJ; Baumgartner BK; Krippner S; Owen SC
    Sci Rep; 2017 Aug; 7(1):8186. PubMed ID: 28811487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-galactosidase omega-complementation with a small cyanogen bromide peptide.
    Welply JK; Mandecki W; Fowler AV; Zabin I
    Biochem Biophys Res Commun; 1980 Mar; 93(1):223-7. PubMed ID: 6769437
    [No Abstract]   [Full Text] [Related]  

  • 18. Restoration of beta-galactosidase to Escherichia coli M15. Complementation studies.
    Marinkovic DV; Marinkovic JN
    Biochem J; 1977 Sep; 165(3):417-23. PubMed ID: 411487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting Protein-Protein Interaction Based on Protein Fragment Complementation Assay.
    Wang T; Yang N; Liang C; Xu H; An Y; Xiao S; Zheng M; Liu L; Wang G; Nie L
    Curr Protein Pept Sci; 2020; 21(6):598-610. PubMed ID: 32053071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of amyloid-β protein precursor homo-interactions using beta-galactosidase enzyme fragment complementation.
    So PP; Chen CD; Abraham CR
    J Alzheimers Dis; 2011; 26(4):647-55. PubMed ID: 21694460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.